Literature DB >> 2915973

Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.

S L Zebedee1, R A Lamb.   

Abstract

The M2 protein of influenza A virus is a 97-amino acid integral membrane protein expressed at the surface of infected cells. Recent studies have shown that a monoclonal antibody (14C2) recognizes the N terminus of M2 and restricts the replication of certain influenza A viruses. To investigate the mechanism of M2 antibody growth restriction, 14C2 antibody-resistant variants of strain A/Udorn/72 have been isolated. Most of the variant viruses are not conventional antigenic variants as their M2 protein is still recognized by the 14C2 antibody. A genetic analysis of reassortant influenza viruses prepared from the 14C2 antibody-resistant variants and an antibody-sensitive parent virus indicates that M2 antibody growth restriction is linked to RNA segment 7, which encodes both the membrane protein (M1) and the M2 integral membrane protein. Nucleotide sequence analysis of RNA segment 7 from the variant viruses predicts single amino acid substitutions in the cytoplasmic domain of M2 at positions 71 and 78 or at the N terminus of the M1 protein at residues 31 and 41. To further examine the genetic basis for sensitivity and resistance to the 14C2 antibody, the nucleotide sequences of RNA segment 7 of several natural isolates of influenza virus have been obtained. Differences in the M1 and M2 amino acid sequences for some of the naturally resistant strains correlate with those found for the M2 antibody variant viruses. The possible interaction of M1 and M2 in virion assembly is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915973      PMCID: PMC286621          DOI: 10.1073/pnas.86.3.1061

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies.

Authors:  W G Laver; G M Air; R G Webster; W Gerhard; C W Ward; T A Dopheide
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

2.  Revertants of temperature-sensitive mutants of reovirus: evidence for frequent extragenic suppression.

Authors:  R F Ramig; B N Fields
Journal:  Virology       Date:  1979-01-15       Impact factor: 3.616

3.  Difference in protein patterns of influenza A viruses.

Authors:  M B Ritchey; P Palese; J L Schulman
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

4.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.

Authors:  R W Compans; H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Evidence for a ninth influenza viral polypeptide.

Authors:  R A Lamb; P R Etkind; P W Choppin
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

6.  Nucleotide sequence coding for the "signal peptide" and N terminus of the hemagglutinin from an asian (H2N2) strain of influenza virus.

Authors:  G M Air
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

7.  Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein.

Authors:  M D Lubeck; J L Schulman; P Palese
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

8.  The matrix protein gene determines amantadine-sensitivity of influenza viruses.

Authors:  A J Hay; N C Kennedy; J J Skehel; G Appleyard
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

9.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Amantadine-resistance as a genetic marker for influenza viruses.

Authors:  G Appleyard
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

View more
  53 in total

1.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.

Authors:  T Watanabe; S Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

5.  Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR.

Authors:  Shu Yu Liao; Keith J Fritzsching; Mei Hong
Journal:  Protein Sci       Date:  2013-10-07       Impact factor: 6.725

6.  Combinatorial approach to hepadnavirus-like particle vaccine design.

Authors:  Jean-Noel Billaud; Darrell Peterson; Margaret Barr; Antony Chen; Matti Sallberg; Fermin Garduno; Phillip Goldstein; Wendy McDowell; Janice Hughes; Joyce Jones; David Milich
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding.

Authors:  Benjamin J Chen; George P Leser; David Jackson; Robert A Lamb
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production.

Authors:  Matthew F McCown; Andrew Pekosz
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  Filamentous influenza virus enters cells via macropinocytosis.

Authors:  Jeremy S Rossman; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

10.  Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.

Authors:  H Jin; K Subbarao; S Bagai; G P Leser; B R Murphy; R A Lamb
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.